Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
about
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costsPharmacogenomics knowledge for personalized medicinePharmacogenomics in the clinicClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Comparison of delivery strategies for pharmacogenetic testing servicesAdvantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics TestingGrand challenges in cellular biochemistry: the "next-gen" biochemistryProgress towards the integration of pharmacogenomics in practiceMaking data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative.Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics CourseClinical pharmacogenetics implementation: approaches, successes, and challengesCYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.Implementation and utilization of genetic testing in personalized medicine.Emerging roles for pharmacists in clinical implementation of pharmacogenomicsPharmacogenetics in clinical practice: how far have we come and where are we going?Evidence that personal genome testing enhances student learning in a course on genomics and personalized medicine.Pharmacogenomics in heart failure: where are we now and how can we reach clinical application?Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.Pharmacogenomics in early-phase clinical developmentPreemptive clinical pharmacogenetics implementation: current programs in five US medical centersCYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes.Pharmacogenetics and cardiovascular disease--implications for personalized medicineThe Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.A pharmacogenetics service experience for pharmacy students, residents, and fellows.Pharmacogenetics and personalized treatment of type 2 diabetesElectronic health record design and implementation for pharmacogenomics: a local perspective.Feasibility of implementing a comprehensive warfarin pharmacogenetics serviceConsidering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Personalized medicine in cardiology: the time for genotype-guided therapy is now.Complexities of CYP2D6 gene analysis and interpretation.Personalized medicine and type 2 diabetes: lesson from epigenetics.Institutional profile: University of Florida Health Personalized Medicine Program.A brighter future for the implementation of pharmacogenomic testing.Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.Disease-drug database for pharmacogenomic-based prescribing.Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.
P2860
Q21284753-52219B59-C92D-4D27-8722-D25C67AA9032Q24623166-6732E5A6-B403-446B-8EAB-32593E535811Q26782786-C948BAC2-DDC2-48DA-861C-D9FF3D4797F9Q26823542-7B1143AE-DA12-43F2-A894-757A3DE3BBE0Q26860925-B90593B0-2311-402A-8EA2-A62C326BEEC3Q28079766-4617946C-61DB-441C-BD4D-484527729F91Q28385256-8C523235-67F8-4537-9F94-457E1BBEE2C8Q28652270-BA533C98-A2CC-4789-B456-888744C20E9EQ30671074-CCF61AE1-6EF9-4343-B3F5-F425354D162AQ30999121-2B91E4B1-6D0D-43D7-8915-55FD835B9ADAQ31137602-3852D687-D69E-4B02-8A70-897DDA8E3F21Q33825186-128A6AB5-D446-4232-B5DC-95899D4DAC61Q33849298-10168C76-88C7-4BE8-A357-DC2556A80422Q33910107-B56E3BCD-D128-4A9A-AA2A-E9A97FDA46EAQ34147916-8FF41487-664F-4B36-B88E-E6D0239CEAE9Q34302434-523AD5A2-DBAC-455C-AC5F-793B328A6A9FQ34343365-DD84D6F7-F966-47BE-A8B9-BA6B59E15E80Q34918731-33A14CAF-0B6B-4927-9AFA-3E7B87E10654Q35086882-F05B2729-4229-40DB-B95B-5C7DC94AE0ABQ35890606-74372529-9F42-4237-9F38-3721949904E9Q36001208-8EDE0115-C194-4873-B340-652741EFD246Q36166107-F3481572-7D02-4DA4-AFA0-903DD1572FC8Q36454174-C32B3964-92AD-4D85-B77F-3F93A19C2B79Q36771188-74E25ACB-6285-40FA-BA9A-8FE1EBCFA577Q36974672-8DF81AC1-236B-45DB-ACCF-06FA40B1E431Q37039082-95DE1D88-A634-4BD7-8027-D41C90A58350Q37251749-6EEBFD08-8A19-49E2-A316-821DD8FF762FQ37508445-A8AC2256-552F-4646-9FC8-1E3EC3846441Q37587527-2799C8FE-C254-47AD-A276-59DE32512D6AQ37700443-A9912693-A15E-46C4-8A99-46BD762B6ABEQ38103885-E6EC2195-F958-4E74-A8BC-085EEC643B12Q38120086-D7D3C185-FB52-4624-85A0-5A088EE60E70Q38154914-D621D2A5-4C57-4E0E-8FD7-35B35F7CE186Q38210476-81A59F6A-71E8-440D-9DAA-84411086F673Q38371889-DB971AE5-4239-49D5-B6DA-C20CC0161003Q38826219-7A930D7E-6F2C-447D-B30C-F35969DE7956Q38848409-5B905CE2-6BF4-47BE-9DA8-FE2F22BF9702Q39062032-F13091F2-C295-42D8-A19B-1DC29E3ABCCEQ39949691-28F43FA0-D514-487B-B1BC-48741A2BC484Q40728342-C41B288A-FFA1-4246-85C9-78CF0F32B647
P2860
Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Implementing personalized medi ...... macogenetics genotyping array.
@ast
Implementing personalized medi ...... macogenetics genotyping array.
@en
type
label
Implementing personalized medi ...... macogenetics genotyping array.
@ast
Implementing personalized medi ...... macogenetics genotyping array.
@en
prefLabel
Implementing personalized medi ...... macogenetics genotyping array.
@ast
Implementing personalized medi ...... macogenetics genotyping array.
@en
P2093
P356
P1476
Implementing personalized medi ...... macogenetics genotyping array.
@en
P2093
B M Burkley
J A Johnson
M J Clare-Salzler
R B Altman
T Y Langaee
P2860
P304
P356
10.1038/CLPT.2012.125
P407
P577
2012-08-22T00:00:00Z